Gating strategy of experiment using 30 min EdU pulses experiments in mOr2-Piwi1 juvenile polyps. by Eudald Pascual-Carreras (12115380)

Difference in patients’ outcomes between years 2022 and 2023. by Rawan T. Tafish (21736177)

Subjects:

Meropenem Consumption Across Quarters of 2022-2023: Defined Daily Dose (Blue Bars) and Antimicrobial Cost per Patient Day (Red Line). by Rawan T. Tafish (21736177)

Subjects:

Estimated Cost Savings and Expenditures During the Gradual Implementation of an AMS Program Across Quarters in 2022–2023. by Rawan T. Tafish (21736177)

Subjects:

Pattern of meropenem prescription expressed as DDD per 1000 across medical specialties: 2022-2023. by Rawan T. Tafish (21736177)

Subjects:

Quarterly Trends in DDD per 1000 Patient-Days and Statistical Comparisons for 2022–2023. by Rawan T. Tafish (21736177)

Subjects:

Descriptive Data of Meropenem Compliance Indicators, 2022–2023. by Rawan T. Tafish (21736177)

Subjects:

Cochran-Armitage Trend test for “Transfer/Discharge” outcome across the quarters of years 2022 and 2023. by Rawan T. Tafish (21736177)

Subjects:

Comparison of Overall Compliance by Clinical Improvement and Transfer/Discharge Outcomes (2022-2023). by Rawan T. Tafish (21736177)

Subjects:

Cochran-Armitage Trend test for “Clinical Improvement within 72 hours” outcome across the quarters of years 2022 and 2023. by Rawan T. Tafish (21736177)

Subjects:

Independent predictors of poor outcome. by Weiyin Lin (16319964)

Two-factor analysis of variance. by Nathan Kelly (17583386)

“…We postulated that decreasing the red:FR by substituting FR light for green light, red light, or both would increase shoot fresh mass (FM) until a fraction beyond which growth (but not leaf area) would begin to decrease. …”

Data Sheet 1_Burden and risk factors for gallbladder and biliary tract diseases in China from 1990 to 2021 and burden predictions of risk factors for the next 15 years.docx by Shijun Zhao (1780339)

“…</p>Conclusion<p>GBDT remains a major global public health problem, and the development trend of GBDT in China has far-reaching global implications. In China, the number of incident cases of GBDT and ASIR increased between 1990 and 2021, and GBDT, due to HBMI, poses a greater disease burden in China, both in the past and in the future.…”

Data and R code from: Managed honey bees aggravate pollination challenges for pollen-limited species in alpine meadows by Erliang Gao (13180272)

“…Overall, plant species with higher degree of pollinator dependency and pollen limitation were more strongly affected by managed honey bees, experiencing a greater extent of decrease in wild pollinator visitation and increase in heterospecific pollen deposition with adjacency to managed hives.…”

<b>Predicting cardiac and renal responses to sacubitril/valsartan with a mathematical model of heart failure with preserved ejection fraction</b> by John Clemmer (11226783)

“…Our model predicted ARNI increased incidence of glomerular HTN, albuminuria, and nephron damage, despite improved glomerular filtration rate and greater decreases in cardiac mass and BP, irrespective of salt intake, warranting further attention for endpoint selection in future clinical studies of these therapies. …”

Supplementary Video 1 by Vina Putra (20363598)

“…If the force balance (ΣF) is greater than zero (1), the cell experiences local compression. …”

Animation 1 by Vina Putra (20363598)

“…If the force balance (ΣF) is greater than zero (1), the cell experiences local compression. …”

Data Sheet 1_Cell specific perfusion rates drive growth dynamics and metabolism in CHO N-1 perfusion processes independent of perfusion rate control method.docx by Julia Walther (3977177)

“…While real-time control offers more precise regulation of the perfusion rate, growth and metabolic behavior is comparable to predefined rates within the tested range. This study demonstrates that optimization of factors such as CSPR, iVVD, and PRI can lead to improved cell growth and viability with the potential to decrease media expenditure, thereby reducing manufacturing costs for the production of mAbs using CHO cell host systems.…”

Image 2_Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.tif by Yue-Yang Zhang (14258160)

“…Following exclusions based on predefined criteria, 9,084 individuals were included in the final analysis. …”

Image 1_Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.tif by Yue-Yang Zhang (14258160)

“…Following exclusions based on predefined criteria, 9,084 individuals were included in the final analysis. …”